HomeQuality Guide

Equipment Qualification in Pharmaceutical Industry: DQ, IQ, OQ, PQ, URS & GMP Requirements

 

Pharmaceutical equipment qualification showing URS DQ IQ OQ PQ lifecycle with GMP equipment and qualification review

Published by: Pharma Quality System Editorial Team Editorial basis: FDA drug CGMP and process-validation guidance, ICH Q7, Health Canada GUI-0001 and GUI-0029, and EU GMP Annex 15
URS • DQ • FAT/SAT • IQ • OQ • PQ • REQUALIFICATION

Equipment qualification is the documented lifecycle used to show that pharmaceutical equipment is suitable for its intended GMP use, installed correctly, operates within defined ranges, and performs effectively under the conditions in which it will actually be used.

Quick answer

A common qualification lifecycle starts with User Requirements Specification (URS), then progresses through Design Qualification (DQ), appropriate vendor/site acceptance activities such as FAT/SAT, Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). The exact structure should be risk-based and appropriate to the equipment and its intended use; some stages may be combined when justified.

Important U.S. regulatory nuance:
FDA drug CGMP does not prescribe one universal DQ–IQ–OQ–PQ template for every piece of drug-manufacturing equipment. U.S. requirements are strongly focused on equipment being appropriately designed, suitable for its intended use, maintained, cleaned, controlled and verified. ICH Q7 explicitly describes DQ, IQ, OQ and PQ for critical equipment and ancillary systems in API manufacture, while Health Canada and EU GMP provide more explicit lifecycle qualification language.

What Is Equipment Qualification in the Pharmaceutical Industry?

Equipment qualification is the documented demonstration that equipment used in pharmaceutical operations is suitable for its intended purpose and can perform consistently within defined conditions. Qualification is applied to manufacturing equipment, laboratory instruments, utilities, support systems and other systems whose performance can affect product quality or GMP decisions.

The practical question is not simply, “Does the machine turn on?” It is: Is this specific equipment, in this configuration, at this site, suitable for the GMP task we intend to perform?

ICH Q7 describes qualification as proving and documenting that equipment or ancillary systems are properly installed, work correctly and lead to the expected results. Health Canada similarly defines qualification as activities demonstrating that facilities, utilities, equipment and processes are suitable for their intended use.

Core idea:
Equipment qualification connects intended use to documented evidence. The evidence should show that the equipment was selected appropriately, installed correctly, challenged across relevant operating conditions and demonstrated to perform as required before it is relied on for GMP production or testing.

Why Equipment Qualification Matters

Pharmaceutical equipment qualification lifecycle from URS and DQ through FAT SAT IQ OQ PQ routine use and requalification

Equipment can become a direct source of product-quality risk when it is poorly designed, incorrectly installed, operated outside a proven range, inadequately maintained or unsuitable for the process. Qualification helps reduce those risks before routine use.

A robust program can help demonstrate that:

  • the equipment is suitable for the intended process or test;
  • critical components and utilities are installed as approved;
  • instruments that influence critical decisions are calibrated and controlled;
  • operating ranges, alarms, interlocks and controls function as intended;
  • the system can perform under actual or representative operating conditions;
  • procedures, maintenance and training requirements are established before routine operation;
  • changes and maintenance activities are evaluated for impact on qualified status.

FDA's equipment CGMP Q&A makes an important point: FDA does not maintain a list of “approved” drug-manufacturing equipment. The manufacturer is responsible for choosing equipment suitable for its intended use and capable of meeting applicable CGMP requirements.

Equipment Qualification vs Validation

The terms are related but should not be used interchangeably.

Term Primary Focus Typical Question
Equipment Qualification Equipment, facilities, utilities or systems Is the equipment fit for its intended use?
Process Validation The manufacturing process across its lifecycle Can the process consistently produce acceptable product?
Computer System Validation GMP computerized-system intended use and controls Can the computerized system reliably perform its regulated intended use?

ICH Q7 explicitly states that qualification is part of validation, but individual qualification steps alone do not constitute process validation. This distinction matters: a perfectly qualified tablet press does not prove that a tablet-manufacturing process is validated.

For the broader lifecycle, see Process Validation in Pharma: FDA Lifecycle, PPQ & Continued Process Verification.

Equipment Qualification Lifecycle

Qualification should be treated as a lifecycle rather than a one-time folder of protocols. The lifecycle begins when the intended use is defined and continues through design, procurement, installation, verification, operation, maintenance, change and eventual retirement.

Typical Qualification Sequence
URS
Define need
DQ
Verify design
FAT/SAT
Acceptance
IQ
Installed right
OQ
Operates right
PQ
Performs in use

This sequence is useful, but it is not a rigid requirement that every project must generate six completely separate documents. EU GMP Annex 15 explicitly allows qualification documents to be combined where appropriate, and Health Canada states that multiple qualification approaches can be acceptable. The structure should match project complexity, risk, intended use and the organization's quality system.

URS - User Requirements Specification

URS and Design Qualification in pharmaceutical equipment showing intended use GMP requirements design review supplier assessment and traceability

The User Requirements Specification (URS) defines what the user needs the equipment to do. It becomes a reference point for design, supplier evaluation, testing and final qualification.

A useful URS may address, as applicable:

  • intended GMP use and process function;
  • capacity, throughput and operating ranges;
  • critical process or equipment parameters;
  • materials of construction and product-contact surfaces;
  • cleanability, drainability or sterilization needs;
  • utilities and environmental requirements;
  • measurement, control, alarms and interlocks;
  • data, audit trail or user-access requirements when computerized functions are involved;
  • maintenance, calibration and spare-parts needs;
  • documentation, manuals, drawings and training expectations.

EU GMP Annex 15 explicitly states that equipment, facility, utility or system requirements should be defined in a URS and/or functional specification, that quality requirements should be built in at this stage, and that the URS should remain a reference throughout the validation lifecycle. Health Canada GUI-0029 likewise describes qualification from initial user requirements through end of use.

Common mistake:
A URS should not be a copy of a vendor brochure. The vendor describes what the equipment offers; the URS should define what the pharmaceutical user actually needs for the intended GMP application.

Design Qualification (DQ)

Design Qualification documents that the proposed design is suitable for its intended purpose. In EU GMP Annex 15, DQ also verifies that the design complies with GMP and that URS requirements have been addressed. ICH Q7 similarly defines DQ as documented verification that the proposed design of facilities, equipment or systems is suitable for the intended purpose.

DQ may review:

  • URS-to-design traceability;
  • equipment capacity and operating concept;
  • product-contact materials;
  • cleaning and contamination-control considerations;
  • instrumentation and control strategy;
  • utility requirements;
  • maintenance access and serviceability;
  • safety and GMP design risks;
  • computerized functions that require separate validation or data-integrity controls.

A strong DQ finds design problems before fabrication and installation, when changes are usually easier and less disruptive than after the equipment arrives at site.

Factory Acceptance Testing (FAT) and Site Acceptance Testing (SAT)

FAT is testing performed at the supplier's facility before shipment. SAT is acceptance testing after the equipment arrives at the user's site. These activities can help identify deficiencies earlier and provide useful qualification evidence.

EU GMP Annex 15 states that novel or complex equipment may be evaluated at the vendor before delivery. It also allows some FAT tests or document reviews not to be repeated later in IQ/OQ when this is justified and when transport and installation cannot affect the tested functionality. Health Canada GUI-0029 gives a similar principle: prequalification tests such as FAT may not need to be repeated when justified.

FAT/SAT are not automatically mandatory for every piece of equipment.
Their use should be proportionate to equipment complexity, risk, project needs and the value of testing before final installation.

Installation Qualification (IQ)

Installation Qualification IQ for pharmaceutical equipment showing equipment ID nameplate utilities materials drawings manuals calibration status and installation location

Installation Qualification verifies that the equipment or system, as installed or modified, matches the approved design, relevant specifications and manufacturer's recommendations.

Typical IQ checks include:

  • equipment identification, model and serial number;
  • correct installation of components, instruments, piping and services;
  • verification against approved drawings and specifications;
  • utilities such as electricity, compressed air, steam, water or HVAC connections, as applicable;
  • materials of construction;
  • instrument identification and calibration status;
  • supplier manuals, operating instructions and maintenance information;
  • critical spare parts and lubricants where relevant;
  • software/firmware versions for equipment containing computerized functions, where applicable.

IQ answers a basic question: Was the approved equipment installed correctly in the intended environment?

Operational Qualification (OQ)

Operational Qualification OQ of pharmaceutical equipment showing operating ranges alarms interlocks sensors control logic worst case conditions and repeatability

Operational Qualification demonstrates that the installed equipment operates as intended throughout relevant operating ranges.

OQ commonly evaluates:

  • start-up, shutdown and normal operating functions;
  • controls, displays, indicators and set points;
  • alarms and interlocks;
  • upper and lower operating limits where scientifically relevant;
  • worst-case or challenge conditions where justified;
  • repeatability of critical equipment functions;
  • response to power loss, utility interruption or fault conditions when relevant to product quality;
  • critical sensors and measuring devices;
  • computerized functions that affect operation, records or GMP decisions.

EU GMP Annex 15 states that successful OQ normally supports finalization of standard operating and cleaning procedures, operator training and preventive-maintenance requirements.

Do not confuse “challenge” with “break the machine.”
Qualification should demonstrate controlled performance over justified operating ranges and relevant challenge conditions. Testing does not need to create unnecessary equipment damage or scientifically irrelevant failure conditions.

Performance Qualification (PQ)

Performance Qualification demonstrates that the equipment or system can perform effectively and reproducibly under actual or representative conditions of use.

EU GMP Annex 15 states that PQ should normally follow successful IQ and OQ, although in some cases PQ may be performed with OQ or process validation. PQ can use production materials, qualified substitutes or simulated product shown to behave equivalently under normal operating conditions, and should cover the intended operating range unless development evidence already supports that range.

Health Canada GUI-0029 similarly expects testing to demonstrate that equipment performs as required under actual production conditions, for example using production materials.

PQ evidence may include:

  • performance using actual or representative materials;
  • defined production loads or batch sizes;
  • repeatability across multiple runs where needed;
  • performance of critical equipment functions under routine conditions;
  • documented results against predefined acceptance criteria.
PQ vs PPQ:
Equipment PQ demonstrates equipment performance. PPQ means Process Performance Qualification and evaluates the commercial manufacturing process. They are connected, but they are not the same study.
Performance Qualification PQ of pharmaceutical equipment under routine conditions with qualified operators multiple runs acceptance criteria and documented performance


DQ vs IQ vs OQ vs PQ - What Is the Difference?

Stage Main Question Typical Evidence
DQIs the proposed design suitable?URS review, drawings, design specs, risk assessment, design traceability
IQWas it installed correctly?Installation checks, utilities, components, manuals, calibration, materials
OQDoes it operate correctly across relevant ranges?Functional tests, alarms, interlocks, limits, operating challenges
PQDoes it perform effectively in actual use?Production/representative materials, routine conditions, repeat performance
DQ vs IQ vs OQ vs PQ comparison in pharmaceutical equipment qualification showing design installation operation and performance stages


Qualification Protocol and Acceptance Criteria

Qualification work should be planned before execution. Health Canada GUI-0029 expects qualification studies to be conducted according to a pre-approved protocol, and EU GMP Annex 15 expects validation protocols to define the critical systems, attributes, parameters and associated acceptance criteria.

A qualification protocol commonly includes:

  • objective and scope;
  • equipment identification and intended use;
  • roles and responsibilities;
  • references to URS, specifications, drawings and procedures;
  • prerequisites;
  • test steps and methods;
  • predefined acceptance criteria;
  • data-recording requirements;
  • deviation handling;
  • approval requirements and final conclusion.

Acceptance criteria should be technically justified and defined before execution. Changing a criterion after seeing an unfavorable result simply to make a study pass undermines the credibility of the qualification.

What Happens When a Qualification Test Fails?

A failed acceptance criterion should not simply be erased, repeated until it passes or rewritten as acceptable. Health Canada GUI-0029 expects failures to meet predefined criteria to be recorded as deviations, with implications for the validation study discussed in the final report. EU GMP Annex 15 similarly requires failed criteria to be recorded as deviations and investigated.

A sound response typically includes:

  1. document the observed failure;
  2. preserve the original data;
  3. evaluate immediate impact on the study;
  4. investigate the cause;
  5. determine whether correction, design change, repair or retesting is scientifically justified;
  6. assess whether completed tests remain valid;
  7. document the final decision and approval.

If the event requires a formal quality-system investigation, see Deviation in Pharmaceutical Industry. Systemic causes may also require CAPA.

Calibration vs Qualification

Calibration and qualification are different controls.

CalibrationQualification
Evaluates measurement performance against a reference or standard. Demonstrates the equipment/system is suitable for its intended use.
Applies to instruments or measuring functions. Can cover the entire equipment, system, utility or facility.
Example: verify a temperature probe against a traceable reference. Example: demonstrate an oven is installed correctly, controls temperature over its working range and performs as required in routine use.

Calibration can be a prerequisite or component of IQ/OQ, but a calibrated instrument does not by itself prove that the entire equipment system is qualified.

Calibration vs qualification in pharmaceutical industry comparing measurement accuracy reference standards with equipment fitness for intended use and documented qualification testing


Requalification - When Is It Required?

Equipment should not be assumed to remain qualified forever simply because the original qualification passed. The qualified state is maintained through appropriate operation, calibration, maintenance, monitoring, change control and periodic evaluation.

Requalification may be considered after:

  • significant equipment modification;
  • relocation;
  • replacement of critical components;
  • major repair or maintenance;
  • software/control-system changes that affect GMP functions;
  • repeated failures, drift or adverse performance trends;
  • changes in intended use or operating range;
  • a justified periodic review requirement.

There is no universal GMP rule that every item of pharmaceutical equipment must be requalified at one fixed interval. EU GMP Annex 15 expects equipment, facilities, utilities and systems to be evaluated at an appropriate frequency to confirm state of control, and says a fixed requalification interval should be justified when used. Health Canada similarly states that where periodic planned requalification is considered necessary, the proposed frequency should be justified.

Pharmaceutical equipment requalification triggers including major maintenance relocation software changes deviations failures process changes utility changes and periodic review


Change Control and Equipment Qualification

Changes to qualified equipment should be evaluated before implementation when they could affect product quality, equipment performance, data integrity, validated processes or the established control strategy.

The change assessment may consider:

  • which URS or design requirements are affected;
  • whether drawings, specifications or procedures need revision;
  • whether calibration or maintenance requirements change;
  • whether IQ, OQ or PQ tests need partial or full repetition;
  • whether process validation, cleaning validation or computerized-system validation is affected;
  • whether training or regulatory documentation is affected.

Health Canada GUI-0029 identifies change control as a key GMP requirement and specifically notes that equipment changes can require updated risk assessments, control strategies and/or requalification. See also our guide to Change Control in Pharmaceutical Industry.

Practical Example: Qualification of a Tablet Compression Machine

URS: Define intended tablet products, throughput range, compression-force capability, speed range, product-contact materials, cleanability, controls, alarms, data requirements and utility needs.

DQ: Verify that the proposed machine design and selected options meet the approved user requirements and GMP needs.

FAT: At the vendor, verify major functions, documentation and agreed acceptance checks before shipment, where justified.

SAT: After delivery, confirm equipment condition, site interfaces and agreed site acceptance checks.

IQ: Confirm correct installation, machine identification, utilities, major components, product-contact materials, documentation and instrument calibration status.

OQ: Challenge controls, speed and compression operating ranges, alarms, interlocks and relevant functional conditions.

PQ: Demonstrate that the machine performs effectively and reproducibly with actual or representative production materials under defined routine operating conditions.

The equipment PQ should not be confused with PPQ of the tablet-manufacturing process. Process PPQ evaluates the broader commercial process, including equipment, materials, personnel, procedures, sampling, testing and process variability.

FDA Expectations for Equipment Qualification

For finished drug products, FDA's CGMP framework focuses on suitability, design, cleaning, maintenance, control and reliable operation of equipment. FDA's current equipment Q&A explains that firms are responsible for selecting equipment appropriate for the intended use and cites 21 CFR 211.63, 211.65, 211.67 and 211.68 as core equipment requirements.

FDA's Process Validation guidance states that before commercial process qualification, facilities and equipment should be qualified and personnel trained. The FDA-hosted ICH Q7 guidance is more explicit for API manufacturing: before process validation, appropriate qualification of critical equipment and ancillary systems should be completed, typically through DQ, IQ, OQ and PQ activities individually or in combination.

A useful U.S. interpretation is therefore:

  • do not look for an FDA-approved equipment list;
  • define intended use and select suitable equipment;
  • qualify or verify critical equipment before relying on it in process validation or GMP production;
  • document objective evidence that the equipment performs as intended;
  • maintain calibration, cleaning, maintenance and change control throughout use.

Health Canada Equipment Qualification Requirements

Health Canada GUI-0001 states that equipment used during critical fabrication, packaging/labelling and testing steps, including computerized systems, should be subject to qualification as identified in the Validation Master Plan, and that equipment qualification should be documented.

GUI-0029 provides the more detailed qualification lifecycle. It expects equipment, facilities and utilities to be appropriately qualified before use in qualification/validation studies or commercial batches. It describes qualification from user requirements through end of use and identifies design suitability, correct manufacture/installation, documentation, calibration, preventative maintenance, operating-range challenges and performance under actual production conditions as important elements.

Health Canada also makes two practical points that are often missed:

  • vendor qualification documents may not fully satisfy the user's GMP needs because the pharmaceutical company understands the intended use better;
  • FAT or other prequalification tests may not need to be repeated later when non-repetition is scientifically justified.

Common Equipment Qualification Mistakes

Copying vendor protocols blindlySupplier documents may not address the site's specific intended use, GMP risks or procedures.
Weak URSIf requirements are vague, design and testing cannot be traced to clear user needs.
Treating IQ as the whole qualificationCorrect installation does not prove correct operation or performance in use.
Testing only nominal conditionsRelevant operating limits and justified challenge conditions may be missed.
Changing acceptance criteria after failureCriteria should be predefined; failures should be investigated, not edited away.
No lifecycle controlMaintenance, changes, drift and repeated failures can undermine qualified status after initial approval.

Equipment Qualification Interview Questions

What is equipment qualification?

It is the documented demonstration that equipment is suitable for its intended GMP use, correctly installed, operates as intended and performs effectively under defined conditions.

What is the difference between IQ, OQ and PQ?

IQ confirms correct installation, OQ confirms operation across relevant ranges, and PQ confirms effective and reproducible performance under actual or representative use conditions.

What is DQ?

DQ verifies that the proposed design is suitable for the intended purpose and, under Annex 15-style qualification, that the design addresses GMP and approved user requirements.

What is the purpose of a URS?

The URS defines what the user needs the equipment or system to do and provides a reference for design, testing, acceptance and qualification.

Can IQ and OQ be combined?

Yes, when appropriate and justified. EU GMP Annex 15 explicitly allows qualification documents to be combined, such as IQ/OQ, depending on project circumstances.

Does every change require full requalification?

No. The extent of requalification should be based on the nature and impact of the change, risk assessment, affected requirements and the existing qualified state.

Strong interview sequence:

Define intended use and URS → assess design and GMP risk → verify installation → challenge operation → demonstrate performance in use → approve results → maintain qualified state through calibration, maintenance, change control and requalification when justified.

Frequently Asked Questions

Is DQ, IQ, OQ and PQ required for every piece of equipment?

Not necessarily as four separate studies. The extent and structure of qualification should be based on intended use, GMP impact, risk and complexity. Critical equipment generally requires documented qualification, but stages may be combined or adapted when justified.

Is a vendor's IQ/OQ package enough?

Not automatically. Vendor documents can be valuable evidence, but the pharmaceutical user remains responsible for showing that the equipment is suitable for its actual intended use and site-specific GMP requirements.

Is FAT part of qualification?

FAT can support qualification and may reduce unnecessary repetition of tests when justified, but it is not universally mandatory for all equipment.

Does equipment PQ replace process PPQ?

No. Equipment PQ verifies equipment performance; process PPQ evaluates whether the commercial manufacturing process can reproducibly produce acceptable product.

How often should equipment be requalified?

There is no single universal interval. Frequency should be justified based on risk, equipment performance, maintenance, changes, regulatory or procedural requirements and the need to confirm continued state of control.

Does calibration mean equipment is qualified?

No. Calibration verifies measurement performance; qualification demonstrates that the broader equipment or system is suitable for its intended use.

Related Pharma Quality Guides

Official and Authoritative Sources

Key takeaway
Equipment qualification is not paperwork performed after installation. It is a lifecycle that begins with intended use and user requirements, verifies design and installation, challenges operation, demonstrates performance under real-use conditions and then preserves the qualified state through maintenance, calibration, monitoring, change control and justified requalification.

Comments

Popular posts from this blog

OOS in Pharmaceutical Industry: Investigation, Phase I & II, Examples

Audit Trail Review in Pharma: FDA, 21 CFR Part 11, HPLC/CDS & Data Integrity

CAPA in Pharmaceutical Industry: Process, Examples & Root Cause Analysis